Kanabo Group (LON:KNB) Stock Price Down 2.2% – Should You Sell?

Kanabo Group Plc (LON:KNB) shares fell 2.2% on Wednesday . The stock traded as low as GBX 0.22 and last traded at GBX 0.22. 11,421 shares traded hands during trading, a decline of 98% from the average session volume of 475,295 shares. The stock had previously closed at GBX 0.23.

Kanabo Group Stock Performance

The company has a market cap of £1.39 million, a P/E ratio of -0.15 and a beta of 3.04. The company’s 50-day moving average is GBX 0.22 and its two-hundred day moving average is GBX 0.22. The company has a quick ratio of 24.36, a current ratio of 5.04 and a debt-to-equity ratio of 3.62.

Kanabo Group Company Profile

Kanabo is creating a new standard in the medical cannabis industry by improving the well-being of millions around the world. Its focus is on the distribution of Cannabis-derived products for medical patients, and non-THC products for CBD consumers.

Kanabo have conducted extensive R&D in order to develop high-quality Cannabis extract formulas, innovative medical-grade vaporisers, and various non-smoking consumption solutions – making use easy and accessible for anyone in need of treatment. Clinical and validation activities, including safety and efficiency tests, are conducted in Israel – an established leader in the Cannabis industry.

The company is selling initial products in Europe already, and is ready to scale up to meet market demands and projected sales and revenues.